DR. CORINNE ZOLLMANN

VP CMC
Pharma
Ato Bio
Israel

Business Expert Clinical Sciences
Biography

Prior to joining Atox Bio in 2014, Dr. Zollmann was Senior Director of Chemistry, Manufacturing and Controls (CMC) at Chiasma. Prior to that, she served for over 20 years in numerous leadership positions at Teva Pharmaceutical’s Global Innovative R&D Division, and most recently, as Director of the CMC Program for Small Molecules. During this period she gained broad experience in global development of innovative pharmaceutical drug products, including CMC management and development, validation, technology transfer,  regulatory strategy and initiatives, and professional CMC project evaluation and due diligence.

Research Intrest

Healthcare

Global Scientific Words in Clinical Sciences